[Journal logo]

Volume 67 
Part 9 
Page o2315  
September 2011  

Received 6 August 2011
Accepted 7 August 2011
Online 11 August 2011

Key indicators
Single-crystal X-ray study
T = 100 K
Mean [sigma](C-C) = 0.002 Å
R = 0.041
wR = 0.106
Data-to-parameter ratio = 16.9
Details
Open access

Ethyl (2E)-2-cyano-3-(1-methyl-1H-pyrrol-2-yl)prop-2-enoate

aChemistry Department, Faculty of Science, King Abdulaziz University, PO Box 80203, Jeddah, Saudi Arabia,bThe Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, PO Box 80203, Saudi Arabia, and cDepartment of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
Correspondence e-mail: edward.tiekink@gmail.com

The 15 non-H atoms of the title compound, C11H12N2O2, are approximately coplanar, the r.m.s. deviation being 0.145 Å. The major deviation from coplanarity is seen in a twist between the ethene (E configuration) and pyrrole rings [C-C-N-C torsion angle = -8.26 (18)°]. The carbonyl O and cyano N atoms are syn to each other. In the crystal, supramolecular linear tapes linked by C-H...O and C-H...N interactions are further connected by C-H...[pi](pyrrole) interactions.

Related literature

For background to the biological activity of 2(1H)pyridone compounds, see: Aly et al. (1991[Aly, A. S., El-Ezabawy, S. R. & Abdel-Fattah, A. M. (1991). Egypt. J. Pharm. Sci. 32, 827-834.]); Al-Saadi et al. (2005[Al-Saadi, S. M., Rostom, S. A. F. & Faid Allah, H. M. (2005). Alex. J. Pharm. Sci, 19, 15-21.]); Rostom et al. (2011[Rostom, S. A. F., Faidallah, S. M. & Al Saadi, M. S. (2011). Med. Chem. Res. doi:10.1007/s00044-010-9469-0.]).

[Scheme 1]

Experimental

Crystal data
  • C11H12N2O2

  • Mr = 204.23

  • Triclinic, [P \overline 1]

  • a = 7.6145 (3) Å

  • b = 8.4964 (6) Å

  • c = 9.7023 (6) Å

  • [alpha] = 64.898 (7)°

  • [beta] = 89.859 (4)°

  • [gamma] = 71.517 (5)°

  • V = 532.69 (5) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.09 mm-1

  • T = 100 K

  • 0.30 × 0.25 × 0.10 mm

Data collection
  • Agilent SuperNova Dual diffractometer with an Atlas detector

  • Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010[Agilent (2010). CrysAlis PRO. Agilent Technologies, Yarnton, England.]) Tmin = 0.955, Tmax = 1.000

  • 4049 measured reflections

  • 2336 independent reflections

  • 1912 reflections with I > 2[sigma](I)

  • Rint = 0.030

Refinement
  • R[F2 > 2[sigma](F2)] = 0.041

  • wR(F2) = 0.106

  • S = 1.04

  • 2336 reflections

  • 138 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.26 e Å-3

  • [Delta][rho]min = -0.21 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the N2,C7-C10 ring.

D-H...A D-H H...A D...A D-H...A
C11-H11a...O2i 0.98 2.31 3.241 (2) 158
C9-H9...N1ii 0.95 2.62 3.557 (2) 171
C11-H11b...Cg1iii 0.98 2.69 3.5332 (17) 144
Symmetry codes: (i) x-1, y+1, z; (ii) -x+1, -y+2, -z; (iii) -x+1, -y+2, -z+1.

Data collection: CrysAlis PRO (Agilent, 2010[Agilent (2010). CrysAlis PRO. Agilent Technologies, Yarnton, England.]); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]) and DIAMOND (Brandenburg, 2006[Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.]); software used to prepare material for publication: publCIF (Westrip, 2010[Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB6354 ).


Acknowledgements

The authors thank King Abdulaziz University and the University of Malaya for supporting this study.

References

Agilent (2010). CrysAlis PRO. Agilent Technologies, Yarnton, England.
Al-Saadi, S. M., Rostom, S. A. F. & Faid Allah, H. M. (2005). Alex. J. Pharm. Sci, 19, 15-21.  [ChemPort]
Aly, A. S., El-Ezabawy, S. R. & Abdel-Fattah, A. M. (1991). Egypt. J. Pharm. Sci. 32, 827-834.  [ChemPort]
Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Rostom, S. A. F., Faidallah, S. M. & Al Saadi, M. S. (2011). Med. Chem. Res. doi:10.1007/s00044-010-9469-0.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.  [ISI] [CrossRef] [ChemPort] [details]


Acta Cryst (2011). E67, o2315  [ doi:10.1107/S1600536811031941 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.